124 related articles for article (PubMed ID: 28139856)
1. Epidemiological investigation of Candida species causing bloodstream infection in paediatric small bowel transplant recipients.
Suhr MJ; Gomes-Neto JC; Banjara N; Florescu DF; Mercer DF; Iwen PC; Hallen-Adams HE
Mycoses; 2017 Jun; 60(6):366-374. PubMed ID: 28139856
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
[TBL] [Abstract][Full Text] [Related]
4. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
[TBL] [Abstract][Full Text] [Related]
5. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
7. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
Gonçalves SS; Amorim CS; Nucci M; Padovan AC; Briones MR; Melo AS; Colombo AL
Clin Microbiol Infect; 2010 Jul; 16(7):885-7. PubMed ID: 19686280
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility profiles and clinical efficacy of antifungals against candida bloodstream isolates from critically ill patients: Focus on intravenous itraconazole.
Giamarellos-Bourboulis EJ; Stamou A; Maraki S; Solomonidi N; Belesiotou E; Pistiki A; Antoniadou E; Vlachogianni G; Mandragos K; Tasioudis C; Katsenos C; Routsi C; Samonis G; Dimopoulos G
Int J Antimicrob Agents; 2019 Oct; 54(4):471-477. PubMed ID: 31271830
[TBL] [Abstract][Full Text] [Related]
10. Three cases of Candida fermentati fungemia following hematopoietic stem cell transplantation.
Morita K; Honda A; Koya J; Toyama K; Ikeda M; Misawa Y; Okugawa S; Nakamura F; Moriya K; Kurokawa M
J Infect Chemother; 2018 Jul; 24(7):576-578. PubMed ID: 29371065
[TBL] [Abstract][Full Text] [Related]
11. Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.
Al-Sweih N; Ahmad S; Joseph L; Khan S; Vayalil S; Chandy R; Khan Z
J Clin Microbiol; 2015 Mar; 53(3):1038-41. PubMed ID: 25568433
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
13. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.
González GM; Treviño-Rangel Rde J; Palma-Nicolás JP; Martínez C; González JG; Ayala J; Caballero A; Morfín-Otero R; Rodríguez-Noriega E; Velarde F; Ascencio EP; Tinoco JC; Vázquez JA; Cano MA; León-Sicairos N; González R; Rincón J; Elías MA; Bonifaz A
J Antimicrob Chemother; 2013 Dec; 68(12):2847-51. PubMed ID: 23869052
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
Purisco SU; Martins MA; Szeszs MW; Castro e Silva DM; Pukinskas SR; Bonfietti LX; Baez AA; Melhem MS
FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
[TBL] [Abstract][Full Text] [Related]
16. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
Breda GL; Tuon FF; Meis JF; Herkert PF; Hagen F; de Oliveira LZ; Dias VC; da Cunha CA; Queiroz-Telles F
Med Mycol; 2018 Jun; 56(4):406-415. PubMed ID: 29420820
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12.
Chen CY; Sheng WH; Huang SY; Chou WC; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
J Antimicrob Chemother; 2015 May; 70(5):1531-8. PubMed ID: 25558079
[TBL] [Abstract][Full Text] [Related]
20. The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality.
Wang E; Farmakiotis D; Yang D; McCue DA; Kantarjian HM; Kontoyiannis DP; Mathisen MS
J Antimicrob Chemother; 2015 Aug; 70(8):2362-8. PubMed ID: 25855759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
